483 Response SCA Pharmaceuticals Nov 2019

Robert Martin FDA$119.00 - Available Now

FDA investigators audited the SCA Pharmaceuticals - Windsor, CT, United States facility and issued inspectional observation (via FDA 483) on 19 Nov 2019.

Product details

  • Category:
  • Inspection end: 19 Nov 2019
  • Location: Windsor, United States
  • FEI: 3013736415
Add To Cart